Ubs Oconnor LLC Acrivon Therapeutics, Inc. Transaction History

Ubs Oconnor LLC

  • $1.44 Billion
  • Q1 2025

A detailed history of Ubs Oconnor LLC transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 15,576 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,576
Holding current value
$0
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
N/A
-87,208 Reduced 84.85%
15,576 $0
Q4 2024

Feb 14, 2025
BUY
N/A
23,535 Added 29.7%
102,784 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-26,000 Reduced 24.7%
79,249 $0
Q2 2024

Aug 14, 2024
SELL
N/A
-21,700 Reduced 17.09%
105,249 $0
Q1 2024

May 15, 2024
BUY
N/A
33,506 Added 35.86%
126,949 $0
Q4 2023

Feb 14, 2024
SELL
N/A
-11,557 Reduced 11.01%
93,443 $0
Q3 2023

Nov 14, 2023
BUY
N/A
5,000 Added 5.0%
105,000 $0
Q2 2023

Aug 14, 2023
BUY
N/A
100,000 New
100,000 $1.3 Billion

Others Institutions Holding ACRV

# of Institutions
61
Shares Held
22.6M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email